ClinicalTrials.Veeva

Menu

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

P

Poitiers University Hospital

Status

Completed

Conditions

Mast Cell Activation Disease
Urticaria Pigmentosa
Mast Cell Disease
Mast Cell Activation Syndrome

Treatments

Other: Ophthalmological examination

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Mastocytosis is a rare condition characterized by an accumulation of mast cell cells in one or more organs such as the liver, bone marrow, spleen and intestines. Its prevalence in the general population is 1 in 10,000.

This pathology is due to the proliferation of a mast cell clone and the excessive release of inflammatory mediators which lead to abnormal tissue infiltration.

To date, there are only a few cases reporting ocular and orbital manifestations of mastocytosis.

Our prospective, interventional and single-center study consist in describing the ocular functional manifestations and ocular surface abnormalities of patients with systemic and cutaneous mastocytosis.

Full description

Patient with systemic or cutaneous mastocytosis will be included in the study. Data about organ involvement of mastocytosis will be collected. Participants will be screened with a medical and eye disease history. They will also have an eye exam.

Participants will provide a tears sample.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have a diagnosis of mastocytosis
  • Male or female, 18 years of age and over
  • Ability to understand and provide written informed consent.

Exclusion criteria

  • Disorders that do not allow good visualization of the posterior pole (cataract, intravitreal hemorrhage)
  • Patients with another ocular pathology that may bias the results (corneal dystrophy, dysthyroid orbitopathy, retinal pathologies)
  • History of refractive surgery

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Participants affected by cutaneous and systemic mastocytosis
Experimental group
Description:
Participants affected by cutaneous and systemic mastocytosis with or without eye disabilities
Treatment:
Other: Ophthalmological examination

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems